Načítá se...
Role of biomarkers for early detection of ovarian cancer recurrence
Ovarian cancer is frequently diagnosed at an advanced stage and a fraction of these patients fail to respond to primary therapy and relapses in 70% of cases. On account of the high recurrence probability and the poor outcomes after recurrence, there is an urgent need to predict progression as early...
Uloženo v:
| Vydáno v: | Gland Surg |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7475347/ https://ncbi.nlm.nih.gov/pubmed/32953625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-544 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|